(4-(4-(4-amino-7,7-dimethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)phenyl)bicyclo(2.2.2)oct-1-yl)acetic acid,
ADPOPBC-acetic acid,
DGAT-1 inhibitor 2,
942999-61-3,
DGAT1 Inhibitor 2,
2-(4-(4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl)bicyclo[2.2.2]octan-1-yl)acetic acid,
2-[4-(4-{4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl}phenyl)bicyclo[2.2.2]octan-1-yl]acetic acid,
DGAT-1,
CHEMBL473384,
SCHEMBL2450536,
BDBM27950,
DTXSID00583287,
VGPKUACRBMPJLF-UHFFFAOYSA-N,
3099AH,
ZINC40913827,
AKOS025149084,
CS-0982,
NCGC00378846-01,
HY-50670,
DB-028469,
FT-0735767,
W-5509,
bicyclo[2.2.2]octane-pyrimido[4,5-b][1,4]oxazine deriv., 4,
{4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]bicyclo[2.2.2]oct-1-yl}acetic Acid,
{4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]bicyclo[2.2.2]octan-1-yl}acetic acid,
2-[4-[4-(4-amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-1-bicyclo[2.2.2]octanyl]acetic acid,
4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]Bicyclo[2.2.2]octane-1-acetic acid,
Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-,
C24H28N4O3,
A3364,
A15067,